Table 3.

Immunoreactive scores of each surface marker in blood vessels from controls and patients with port-wine stains (PWS)

Patient no.	Age/sample		CD133	CD166	EphB1	EfnB2
1	Infant	S	2	3	0	2
2	Infant	T	6	6	6	2
3	Infant	Ex	4	6	6	4
4	Infant	S	3	6	4	4
5	Paediatric	T	4	6	1	3
6	Paediatric	T	6	6	1	4
7	Paediatric	T	4	6	1	4
8	Paediatric	F	4	4	2	2
9	Paediatric	T	4	6	3	2
10	Paediatric	F	4	6	4	3
11	Paediatric	F	6	6	1	3
12	Paediatric	F	3	4	0	1
13	Paediatric	F	4	6	6	4
14	Paediatric	F	4	4	1	2
15	Paediatric	Ex	2	4	4	1
16	Teen.	F	2	4	4	4
		E	2	3	4	4
17	Teenage	F	6	3	3	2
		E	3	2	2	6
18	Adult	F	2	2	4	2
		E	0	0	4	1
19	Adult	Ex	2	2	4	3
20	Adult	S	6	6	0	3
21	Adult	S	0	1	6	0
22	Adult	F	6	6	4	6
		N	6	6	1	4
23	Adult	F	3	3	4	4
		E	2	2	4	4
24	Adult	F	2	2	4	4
		E	0	0	4	0
		D-l	0	0	0	2
		D-2	0	0	4	2
25	Adult	F	2	1	6	1
26	Adult	F	2	0	6	1
27	Adult	F	3	1	4	1
		D	1	0	1	0
Control 1	Paediatric	F	2	1	1	2
Control 2	Paediatric	F	2	2	1	3
Control 3	Paediatric	Ex	1	1	1	2
Control 4	Paediatric	F	2	3	1	3
Control 5	Adult	Ex	0	0	0	1
Control 6	Adult	Ex	0	0	0	1
Control 7	Adult	F	0	0	0	2
Control 8	Adult	F	0	0	0	3
Control 9	Adult	Ex	0	0	0	2

EphB1, Eph receptor B1; Efn-B2, ephrin B2; S, scalp; T, trunk; Ex, extremity; F, facial; N, neck; E, edge of PWS lesion sites; D, nodular PWS.